Oropharyngeal neoplasms are tumors or cancers that develop in the oropharynx. The oropharynx is the part of your throat behind your mouth and above your neck. These cancers can develop in the tonsils or the back of the throat. They are often linked to HPV infection.
Every report comes from a Lived member, sent anonymously.
Have you tried Radiation Therapy for Oropharyngeal Tumors?
Oropharyngeal tumors are growths that start in the oropharynx, the middle part of the throat just behind the mouth. The oropharynx includes the back third of the tongue, the tonsils, the soft palate (the soft back part of the roof of the mouth) and the side and back walls of the throat. Because food and air both pass through it, a tumor here can affect swallowing and speech. The tumors that matter most in this area are cancers. Oropharyngeal cancer is a type of head and neck cancer, and it usually begins in the thin, flat squamous cells that line the throat. Doctors now divide it into two groups: cancers caused by human papillomavirus (HPV) and cancers that are not. The difference is practical, not academic. The two groups tend to affect different people, are staged on different scales and respond differently to treatment. Early cancer may cause no symptoms. When symptoms appear, they can include a sore throat that does not go away, trouble swallowing, ear pain, difficulty opening the mouth fully or moving the tongue, unexplained weight loss and coughing up blood. A lump in the neck is sometimes the first sign. The cancer can spread to lymph nodes in the neck early, and occasionally a swollen node is found before the original tumor is.
Most oropharyngeal cancers arise along one of two paths. The first is long-term damage to the throat lining from tobacco and alcohol. Chemicals in tobacco smoke damage the DNA of the lining cells, and heavy drinking helps those chemicals do more harm. Together the effect multiplies: for mouth and throat cancers combined, people who both smoke and drink heavily have about 30 times the risk of people who do neither. Chewing betel quid, a stimulant mixture used in parts of Asia, also raises risk. The second path is infection with HPV, mainly type 16. HPV is a very common virus spread through sexual contact, including oral sex, and the immune system usually clears it. When a high-risk type persists in the throat, it can switch off genes that normally restrain cell growth. Signs of HPV are found in about two out of three oropharyngeal cancers, and HPV-linked cases have risen sharply over recent decades, increasingly in younger people who have never smoked or drunk heavily. Most people with an HPV infection of the mouth or throat never develop this cancer. Men are about twice as likely as women to develop these cancers. A previous head and neck cancer and rare inherited conditions such as Fanconi anemia also raise risk. Many people diagnosed have few of these risk factors, and having one does not mean it caused a particular person's cancer. The HPV vaccine Gardasil 9 is approved for people 9 through 45 years old to help prevent oropharyngeal and other head and neck cancers caused by the HPV types it covers. It works best before any exposure to the virus, which is why it is recommended at a young age. That approval rests on the vaccine's proven prevention of other HPV-related disease rather than direct proof in throat cancer, and it does not treat an existing infection or cancer.
An evaluation starts with questions about symptoms, smoking, drinking and health history, then a careful look at the mouth, throat and neck. Because the oropharynx sits deep in the throat, an ear, nose and throat specialist (otolaryngologist) usually examines it with a small mirror or a thin, flexible camera passed through the nose or mouth. Only a biopsy can confirm cancer: a piece of tissue or a sample of cells is removed and examined under a microscope. A suspicious neck lump is often sampled with a thin needle, sometimes guided by ultrasound. CT, MRI and PET-CT scans show how large the tumor is, whether it has grown into nearby structures and whether it has spread to lymph nodes or other parts of the body. Because people with these cancers, particularly those who have smoked and drunk heavily, can have a second cancer at the same time, some have a panendoscopy: an exam under general anesthesia of the throat, voice box, esophagus and airways. The biopsy is also tested for HPV, usually by checking for a protein called p16 that signals HPV-driven cancer. This result shapes the stage, treatment options and outlook. Stage runs from I to IV and reflects the size of the tumor, how many neck lymph nodes are involved, how large they are and on which side, and whether the cancer has reached distant organs. HPV-positive and HPV-negative cancers are staged on separate scales, so the same stage number does not mean the same thing for both.
Treatment is planned by a team experienced in head and neck cancer: typically a head and neck surgeon, a radiation oncologist and a medical oncologist, with dentists, dietitians and speech and swallowing therapists. The team weighs two goals together: removing or destroying the cancer, and keeping speech and swallowing as normal as possible. For early-stage cancer (stage I or II), the main choices are surgery or radiation therapy. Surgery for tumors of the tonsil or back of the tongue can often be done through the mouth, sometimes with transoral robotic surgery, in which the surgeon guides small instruments on robotic arms using a magnified 3D camera view. If the removed tissue shows a higher chance of the cancer returning, radiation, sometimes with chemotherapy, may follow. For more advanced cancer (stage III, or stage IV that has not spread to distant organs), the usual approach is chemoradiation: radiation with chemotherapy given during the same weeks, commonly cisplatin, a platinum-based chemotherapy drug. People who cannot take that chemotherapy may have radiation alone or radiation with cetuximab (Erbitux), a targeted drug that blocks a growth signal on cancer cells. HPV status can affect treatment choices, and clinical trials are testing whether some people with HPV-positive cancer can safely receive less intensive treatment, such as surgery through the mouth followed by lower-dose radiation. Radiation is usually given five days a week for about seven weeks. Techniques such as intensity-modulated radiation therapy (IMRT) shape the beams to spare nearby healthy tissue, and a fitted mesh mask holds the head still for each session of a few minutes. A dental exam before radiation is important, because radiation makes later tooth problems and jawbone damage more likely, and unhealthy teeth may need removing first. When cancer has spread to distant organs or comes back after treatment, immunotherapy drugs that help the immune system attack cancer cells are central. Pembrolizumab (Keytruda) can be used alone or with chemotherapy, and nivolumab (Opdivo) is an option when cancer grows despite platinum chemotherapy. A test of the tumor for a marker called PD-L1 helps show who is likely to benefit. Pembrolizumab is also approved for some people with advanced cancer that can still be removed surgically, given before surgery and continued afterward. A recurrence limited to the throat or neck may sometimes be treated with further surgery or radiation. For cancer that cannot be cured, ongoing treatment aims to keep it under control and ease symptoms. Stopping smoking is part of treatment. Radiation may work better in people who have quit, and smoking during or after treatment raises the chance of the cancer returning and of a new cancer.
Treatment for oropharyngeal cancer is demanding because it targets the area used to eat, drink and speak. During radiation, the mouth and throat often become sore, with painful sores, dry mouth, loss of taste, hoarseness, sunburn-like skin changes on the neck and fatigue. Eating can become hard enough to cause weight loss, and some people need a feeding tube into the stomach for a time. Dietitians and speech therapists help through this period, and swallowing exercises help keep the throat muscles working. Most short-term effects ease in the weeks and months after treatment, but some can last. Damage to the salivary glands can leave a permanently dry mouth, which makes tooth decay more likely, so careful oral hygiene, regular dental visits and fluoride treatments become long-term habits. Some people keep having trouble swallowing because radiation stiffens the throat muscles. Radiation can also slow the thyroid gland, which is checked with periodic blood tests, and less often it damages the jawbone (osteoradionecrosis), a problem that usually shows up as jaw pain and is more likely after a tooth extraction or infection. Outlook depends mainly on HPV status, smoking history, stage and how many lymph nodes are involved. HPV-positive cancers have a better outlook and are less likely to come back, although the advantage is smaller in people who smoke. Five-year relative survival compares people with the cancer to similar people without it. In US data for oropharyngeal cancer of all types combined, it is about 86% when the cancer is still confined to the throat at diagnosis, about 79% when it has spread to nearby lymph nodes or tissues, and about 40% when it has reached distant organs. These figures do not separate HPV-positive from HPV-negative cancer, and they come from people diagnosed years ago. Follow-up continues for years. Head and neck exams are frequent in the first year after treatment, every 6 to 12 weeks, and space out to every 6 months after about three years. Survivors have a higher risk of a second cancer of the head and neck, lungs or esophagus, and that risk is greater with continued smoking or drinking.
Arrange an evaluation for a sore throat or trouble swallowing that does not go away, a lump in the neck or at the back of the mouth, persistent ear pain, unexplained weight loss, or difficulty opening the mouth or moving the tongue. These problems often have other causes, but persistent ones deserve a proper look at the throat, often by an ear, nose and throat specialist. During or after treatment, contact your care team right away about any new symptom, or if you cannot eat or drink enough to keep up your weight and fluids. New pain, bleeding or a sore that does not heal can signal a treatment effect or returning cancer, and jaw pain after radiation, especially following dental work, needs prompt attention from both your care team and your dentist.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Oropharyngeal Tumors is like, what's helped you, or ask the community a question.